CompoAtlas

NICORETTE InvisiPatch 5 mg/16h

Natural health product licensed in Canada

Licence holder
McNeil Consumer Healthcare, division of Johnson & Johnson Inc.
NPN or DIN-HM
80022989
Status
Inactive licence
Licence date
23 December 2010
Revision date
Not provided
Form
Timbre transdermique
Route of administration
Transdermique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

triglycérides à chaînes moyennes, Croscarmellose de sodium, Polyethylene terephthalate, Durotak 387-2051, Eudragit-E, Potassium Hydroxide, Butylated methacrylate copolymer

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 patch1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

NICORETTE InvisiPatch 5 mg/16 hr offers controlled-release nicotine throughout the day to reduce withdrawal symptoms and nicotine cravings. To increase your chance of quitting use with a stop smoking support program. Combination Treatment: If you have relapsed or if you have had intense cravings or you feel like your cravings are overwhelming while using the patch alone, now you can use the patch in combination with NICORETTE Gum 2 mg for better craving relief. Combination Treatment: Use the patch as directed and chew 5-6 pieces of gum per day (maximum 15 pieces/day). Now, for the first time, you can wear NICORETTE Patch and chew NICORETTE Gum 2 mg together at the same time to help conquer those intense or overwhelming cravings and increase your chances of quitting vs. patch or gum alone.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80022989

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line